RWD Data Insights: Linkage of patient services and real-world healthcare data
Explore UBC’s study to see how linking patient support programs and RWD is a source of valuable insights into the patient healthcare journey.
Enriching clinical studies with longitudinal real-world data
Download our case study to explore how UBC linked clinical trial data with six years of pre- and post-trial patient healthcare data, for rich longitudinal real-world evidence development.
Clinical Trial Diversity Action Plan Development Checklist
Download our checklist “Clinical Trial Diversity Action Plan Development Checklist” to ensure your clinical study is compliant with FDA Draft Guidance.
The Vital Role of Diversity in Clinical Trials
Download our white paper The Vital Role of Diversity in Clinical Trials for a three-pronged approach to help address clinical trial enrollment and participation gaps.
Personalized Medicine: A Primer on the Role of Pharmacogenetics and Pharmacogenomics in Oncology
This white paper discusses personalized medicine, applications of pharmacogenetics/pharmacogenomics in oncology and the positive impact they have on drug development.
Recently Approved Cell-Based Gene Therapies Demonstrate Innovation in Sickle Cell Disease Treatment
This white paper offers a comprehensive primer on the burden of SCD, the patient journey, and current and emerging treatment options.
Understanding the Natural History of Disease
Learn more about the benefits of natural history studies in drug development.
The Joint Clinical Assessment: Anticipating Challenges and Opportunities
This white paper provides an essential overview of the regulations, a brief history, and an in-depth look at the EU’s Health Technology Assessment Regulation 2021/2282.
Gain Strategic Insights by Linking Clinical Trial Data to Real World Data
Read our white paper to explore how integrating RWD/RWE with clinical trial data can overcome challenges and enhance regulatory submissions.
